Morphotek has acquired three buildings in Exton, PA with plans to raze them and build an $80 million manufacturing facility that will make experimental drugs for clinical trials. "Ultimately, our goal is to be a fully integrated biopharmaceutical company and having your own manufacturing facility is part of that process," says CEO Nicholas Nicolaides. Report